这个是zhang feng的公司# Stock
b*s
1 楼
Gates, Google Join $120 Million Funding for Genome Editing Firm
Editas Medicine Inc. has raised $120 million from investors to support
development of a technology that can precisely edit DNA and potentially
treat fatal genetic diseases.
By Caroline Chen - Aug 10, 2015, 4:30:00 AM
Editas Medicine Inc. has raised $120 million from investors to support
development of a technology that can precisely edit DNA and potentially
treat fatal genetic diseases.
By Caroline Chen - Aug 10, 2015, 4:30:00 AM